COVID19: Useful Resources
Last updated on 01/04/2021
Current Highlights
'As the expertise of our team spans nutrition research, clinical practice and public health, we are well-positioned in the international effort to improve human health during the COVID-19 pandemic. Together, we have collated data and resources that are most relevant to current knowledge and practice relating to COVID-19, specifically in its relation to nutrition, on our dedicated microsites’
Recent microsite highlights include:
-
Obesity, ethnicity and risk of critical care, mechanical ventilation and mortality in patients admitted to hospital with COVID‐19: Analysis of the ISARIC CCP‐UK cohort
-
Obesity, walking pace and risk of severe COVID-19 and mortality: analysis of UK Biobank
-
JAMA: Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19
-
Vaccines:
-
EMA Greenlight Jansen Vaccine
-
.
World Health Organisation (WHO)
-
Advice on the use of masks in the context of COVID-19 -
Information: What is Coronavirus? -
How to protect yourself -
Community-based health care, including outreach and campaigns in the context of the COVID-19 pandemic -
Monitoring: Situation Dashboard documenting cases, deaths and affected areas -
Maintaining essential health services: operational guidance for the COVID-19 context -
Rolling updates on Covid-19 -
Training: COVID-19: Operational Planning Guidelines and COVID-19 Partners Platform to support country preparedness and response -
Coronavirus (COVID-19): Vaccines
Europe
- European Centre for Disease Prevention and Control
-
COVID-19 in children and the role of school settings in transmission - first update -
Wearing and removing PPE
United Nations (UN)
- United Nations Global Call Out To Creatives - help stop the spread of COVID-19
-
UN Human Rights during COVID-19
Elsevier
- Novel Coronavirus Information Center: Elsevier’s free health and medical research on novel coronavirus (COVID-19).
-
Novel Coronavirus (Covid-19) Information Center for nursing and healthcare educators.
Centre for Disease Control (CDC)
- Scientific Brief: Community Use of Cloth Masks to Control the Spread of SARS-CoV-2
-
New CDC Guidance for Vaccinated Americans
Vaccines
Pfizer
-
Our progress in developing a potential COIVD-19 vaccine -
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine -
Delayed second dose of the BNT162b2 vaccine: innovation or misguided conjecture? -
Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine
-
Potential vaccine againd Covid-19 -
BMJ article: Covid-19: Moderna vaccine is nearly 95% effective, trial involving high risk and elderly people shows
-
Oxford-AstraZenica vaccine -
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine -
EMA COVID-19 Vaccine Safety March 2021 Update
-
Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use - First Single-Shot Vaccine in Fight Against Global Pandemic -
FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine -
EMA Greenlight Jansen Vaccine
-
COVAX and Vaccine Disparities -
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment -
COVID-19 Vaccination Tracker
International Guidance
Click on the links to expand the content
Educational Courses
- World Health Organisation (WHO)
-
eLearning for Healthcare -
Imperial College London -
London School of Tropical Medicine (LSTM) -
University of Alberta: COVID-19 and the Economics of World Food & Agriculture -
RGCP eLearning
Research
Journals
-
British Medical Journal (BMJ) -
Frontiers: Coronavirus Hub -
Journal of the American Medical Association (JAMA) -
Lancet -
New England Journal of Medicine (NEJM)
-
Child malnutrition and COVID-19: the time to act is now -
Impacts of COVID-19 on childhood malnutrition and nutrition-related mortality -
COVID-19 in Latin America: a humanitarian crisis -
Data and Policy to Guide Opening Schools Safely to Limit the Spread of SARS-CoV-2 Infection -
SARS-CoV-2 variants and ending the COVID-19 pandemic -
BMJ Open: Understanding Vaccine Efficacy Measures -
Access to COVID-19 vaccines: Looking beyond COVAX
-
British Medical Journal (BMJ): Covid-19 and community mitigation strategies in a pandemic -
BMJ: Is ethnicity linked to incidence or outcomes of covid-19? -
Imperial College COVID-19 Response Team: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID- 19 mortality and healthcare demand -
The Lancet: Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study -
The Lancet: Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis -
The Lancet: Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis -
Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study -
Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020 -
Place and causes of acute cardiovascular mortality during the COVID-19 pandemic -
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study -
Real-time tracking of self-reported symptoms to predict potential of COVID-19 -
Vulnerable Workers and COVID-19: Insights from a Survey of Members of the International Commission for Occupational Health -
WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) -
Centre for Disease Control (CDC): Case Report Data -
Key concepts on COVID-19 and the response to support thinking about health inequalities -
PHE monitoring of the early impact and effectiveness of COVID-19 vaccination in England -
National Institute for Health Research (NIHR) - Call for research proposals for a randomised trial to evaluate vaccine clinical effectiveness for the UK COVID-19 immunisation programme -
Covid-19 vaccine hesitancy among ethnic minority groups -
Covid-19: Pfizer BioNTech vaccine reduced cases by 94% in Israel, shows peer reviewed study
-
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report - COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing
-
Immune Response to COVID -
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients -
Persistent hypermetabolism and longitudinal energy expenditure in critically ill patients with COVID-19 - Obesity and Critical Illness in COVID‐19: Respiratory Pathophysiology
-
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents -
The proximal origins of SARS CoV-2 -
Pre Print: Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection - Pre Print: The timing of COVID-19 Transmission
- Sex differences in immune responses that underlie COVID-19 disease outcomes
- Obesity, walking pace and risk of severe COVID-19 and mortality: analysis of UK Biobank
- Obesity, ethnicity and risk of critical care, mechanical ventilation and mortality in patients admitted to hospital with COVID‐19: Analysis of the ISARIC CCP‐UK cohort
-
Cell Metabolism: Association of Blood Glucose Control and Outcomes in COVID-19 -
Could Insulin Resistance Mediate the Severity of COVID-19 infection? -
NHS England: Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study -
NHS England: Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a cohort study in people with diabetes -
Prevention and management of COVID-19 among patients with diabetes: An appraisal of the literature -
Coronavirus Disease 2019 (COVID-19) Meets Obesity: Strong Association between the Global Overweight Population and COVID-19 Mortality
Reviews:
Trials:
- BMJ: Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
- BMJ: Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study
- The Lancet: Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- A phase 1/2/3, placebo-controlled, randomized, observer-blind, dose-finding study to evaluate the safety, tolerability, immunogenicity, and efficacy of SARS-COV-2 RNA vaccine candidates against covid-19 in healthy individuals (Pfizer/BioNTech)
Interesting Articles
-
Why You Should Ignore All That Coronavirus-Inspired Productivity Pressure -
Coronavirus: Why you must act now -
Flattening the Curve -
WHO: What is Coronavirus? -
Harvard Med Students Infographic -
New York Times – Tracking of Coronavirus spread -
Coronovirus Tracked – Financial Times -
Coronavirus masks: What’s the latest evidence? -
Going viral: how to boost the spread of coronavirus science on social media -
Vox Long COVID -
The Government’s obesity plan ignores the factors that mean body weight is not a choice – Giles Yeo -
The way Italy handled its second wave is a lesson for us all -
How COVID-19 Is Transforming The Fitness Industry -
Covid-19: India sees new spike in cases despite vaccine rollout
Support
- WHO: Mental Health Considerations during COVID-19 Outbreak
-
BMJ: Mitigating the psychological effects of social isolation during the COVID-19 pandemic -
Help for extremely vulnerable populations -
Role of Palliative Care in COVID19 Pandemic -
Beat COVID: Wellbeing strategy for Healthcare workers - Nutritank -
Covid-Calm - Nutritank -
5 Ways to Fix Your Day -
What sitting is doing to your body -
WHO #HealthyAtHome
Recovery
- BMJ: Returning to physical activity after covid-19
-
Long-term follow-up of recovered patients with COVID-19 -
Returning to Physical Activity after COVID-19 -
Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19 -
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study
Additional Resources
Click on the links to expand the content
Educational Courses
- World Health Organisation (WHO)
-
eLearning for Healthcare -
Imperial College London -
London School of Tropical Medicine (LSTM) -
University of Alberta: COVID-19 and the Economics of World Food & Agriculture -
RGCP eLearning
Research
Journals
-
British Medical Journal (BMJ) -
Frontiers: Coronavirus Hub -
Journal of the American Medical Association (JAMA) -
Lancet -
New England Journal of Medicine (NEJM)
-
Child malnutrition and COVID-19: the time to act is now -
Impacts of COVID-19 on childhood malnutrition and nutrition-related mortality -
COVID-19 in Latin America: a humanitarian crisis -
Data and Policy to Guide Opening Schools Safely to Limit the Spread of SARS-CoV-2 Infection -
SARS-CoV-2 variants and ending the COVID-19 pandemic -
BMJ Open: Understanding Vaccine Efficacy Measures -
Access to COVID-19 vaccines: Looking beyond COVAX
-
British Medical Journal (BMJ): Covid-19 and community mitigation strategies in a pandemic -
BMJ: Is ethnicity linked to incidence or outcomes of covid-19? -
Imperial College COVID-19 Response Team: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID- 19 mortality and healthcare demand -
The Lancet: Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study -
The Lancet: Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis -
The Lancet: Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis -
Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study -
Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020 -
Place and causes of acute cardiovascular mortality during the COVID-19 pandemic -
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study -
Real-time tracking of self-reported symptoms to predict potential of COVID-19 -
Vulnerable Workers and COVID-19: Insights from a Survey of Members of the International Commission for Occupational Health -
WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) -
Centre for Disease Control (CDC): Case Report Data -
Key concepts on COVID-19 and the response to support thinking about health inequalities -
PHE monitoring of the early impact and effectiveness of COVID-19 vaccination in England -
National Institute for Health Research (NIHR) - Call for research proposals for a randomised trial to evaluate vaccine clinical effectiveness for the UK COVID-19 immunisation programme -
Covid-19 vaccine hesitancy among ethnic minority groups -
Covid-19: Pfizer BioNTech vaccine reduced cases by 94% in Israel, shows peer reviewed study
-
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report - COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing
-
Immune Response to COVID -
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients -
Persistent hypermetabolism and longitudinal energy expenditure in critically ill patients with COVID-19 - Obesity and Critical Illness in COVID‐19: Respiratory Pathophysiology
-
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents -
The proximal origins of SARS CoV-2 -
Pre Print: Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection - Pre Print: The timing of COVID-19 Transmission
- Sex differences in immune responses that underlie COVID-19 disease outcomes
- Obesity, walking pace and risk of severe COVID-19 and mortality: analysis of UK Biobank
- Obesity, ethnicity and risk of critical care, mechanical ventilation and mortality in patients admitted to hospital with COVID‐19: Analysis of the ISARIC CCP‐UK cohort
-
Cell Metabolism: Association of Blood Glucose Control and Outcomes in COVID-19 -
Could Insulin Resistance Mediate the Severity of COVID-19 infection? -
NHS England: Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study -
NHS England: Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a cohort study in people with diabetes -
Prevention and management of COVID-19 among patients with diabetes: An appraisal of the literature -
Coronavirus Disease 2019 (COVID-19) Meets Obesity: Strong Association between the Global Overweight Population and COVID-19 Mortality
Reviews:
Trials:
- BMJ: Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
- BMJ: Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study
- The Lancet: Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- A phase 1/2/3, placebo-controlled, randomized, observer-blind, dose-finding study to evaluate the safety, tolerability, immunogenicity, and efficacy of SARS-COV-2 RNA vaccine candidates against covid-19 in healthy individuals (Pfizer/BioNTech)
Interesting Articles
-
Why You Should Ignore All That Coronavirus-Inspired Productivity Pressure -
Coronavirus: Why you must act now -
Flattening the Curve -
WHO: What is Coronavirus? -
Harvard Med Students Infographic -
New York Times – Tracking of Coronavirus spread -
Coronovirus Tracked – Financial Times -
Coronavirus masks: What’s the latest evidence? -
Going viral: how to boost the spread of coronavirus science on social media -
Vox Long COVID -
The Government’s obesity plan ignores the factors that mean body weight is not a choice – Giles Yeo -
The way Italy handled its second wave is a lesson for us all -
How COVID-19 Is Transforming The Fitness Industry -
Covid-19: India sees new spike in cases despite vaccine rollout
Support
- WHO: Mental Health Considerations during COVID-19 Outbreak
-
BMJ: Mitigating the psychological effects of social isolation during the COVID-19 pandemic -
Help for extremely vulnerable populations -
Role of Palliative Care in COVID19 Pandemic -
Beat COVID: Wellbeing strategy for Healthcare workers - Nutritank -
Covid-Calm - Nutritank -
5 Ways to Fix Your Day -
What sitting is doing to your body -
WHO #HealthyAtHome
Recovery
- BMJ: Returning to physical activity after covid-19
-
Long-term follow-up of recovered patients with COVID-19 -
Returning to Physical Activity after COVID-19 -
Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19 -
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study
Regional Guidance
Click on the links to expand the content
NNEdPro COVID-19 Task Force:
Executive Members
-
Dr Dominic Crocombe: Co-Chair
-
Prof Sumantra Ray RNutr: Co-Chair
-
Shane McAuliffe RD: Deputy Co-Chair (Lead for science communications, Microsite, and links with BMJ NPH)
-
Sucheta Mitra: Deputy Co-Chair (Lead for operational support and internal communications)
BMJ Nutrition Prevention and Health Members
-
Prof Martin Kohlmeier: Editor in Chief, BMJ NPH
-
Prof Bryndís Eva Birgisdóttir: Associate Editor, BMJ NPH
Attending Members
-
Elaine Macaninch RD: Lead for Patient, Public and Practitioner Outreach
-
Dr Luke Buckner: Lead for Nutritional Inequities and Educational Policy
-
Dr Marjorie Lima do Vale RD: Lead for Advocacy and Impact
-
James Bradfield RD: Lead for Education, Awareness, and Implementation
-
Dr Kaninika Basu: Advice on Food, Allergy, and Immunology
-
A/Prof Luigi Palla: Advice on Statistics and Epidemiology
-
Dr Marcello Scopazzini: Advice on Infectious Diseases Medicine
-
Sonigitu Ekpe: Advice on Agriculture and Food Security
-
Niky Raja: Public Health and Microsite Support
Corresponding Members
-
Matheus Abrantes: Digital and Microsite Lead
-
Dr Shobhana Nagraj: Maternal and Child Health
-
Dr Claudia Mitrofan: Science and Clinical Research
-
Helena Trigueiro RD: Representative for Regional Networks
-
Pauline Douglas RD: Representative for Directors (on behalf of Prof Dan Del Rio, Dr Celia Laur RNutr & Dr Minha Rajput-Ray)
Former Members (2020)
-
Dr Suzana Almoosawi (Science Research)
-
Dr Harrison Carter (Policy Outreach)
-
Dr Timothy Eden RD (Clinical Research)
-
Emily Fallon ANutr (Public Health)
-
Dr Lyn Haynes (Education & Networks)